Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma
- PMID: 16360410
- DOI: 10.1016/j.humpath.2005.09.024
Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma
Abstract
Focal adhesion kinase (FAK) is one of the central signaling molecules found at focal adhesion sites, which are specific areas on the cell membrane where cells attach to extracellular matrix proteins. Focal adhesion kinase interacts with multiple signaling and adaptor molecules and effects several signaling pathways. Overexpression of FAK and its substrate c-Src has been implicated in malignant transformation and acquisition of an invasive tumor phenotype of different tissues. Overexpression of the multidomain protein paxillin, which is also a FAK ligand and a c-Src substrate, has been associated with less malignant tumor behavior. The purpose of this study was to analyze the involvement of integrin signaling molecules FAK, c-Src, and paxillin in malignant transformation of the breast epithelium. Using phosphospecific antibodies FAK-pY(397) and Src-pY(416), we demonstrated that neither activation of FAK nor activation of c-Src correlates with development of invasive tumor properties. However, activation of both FAK and c-Src correlates with malignant transformation. We further demonstrated that overexpression of paxillin also correlates with malignant transformation and is a marker of a less invasive tumor phenotype. Using tissue microarray, we demonstrated that expression and activation of paxillin inversely correlated with lymph node metastases and lymphovascular invasion, respectively. No correlation between paxillin expression and activation and tumor grade, estrogen, progesterone, and Her2/Neu receptor expression was found. In summary, focal adhesion proteins FAK and c-Src can be used as markers of malignant transformation in epithelial cells but not invasive phenotype, whereas expression and activation of paxillin may represent a good prognosticator in breast carcinoma.
Comment in
-
Imaging focal adhesion kinase activation in breast cancer-promoting cell proliferation and carcinogenesis, but not migration, invasion, or metastatic predilection.Hum Pathol. 2006 Sep;37(9):1241-2; author repy 1242. doi: 10.1016/j.humpath.2006.04.018. Epub 2006 Jul 18. Hum Pathol. 2006. PMID: 16938535 No abstract available.
Similar articles
-
Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity.Med Sci Monit. 2009 Aug;15(8):BR221-6. Med Sci Monit. 2009. PMID: 19644410
-
Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.J Biomed Sci. 2005;12(4):571-85. doi: 10.1007/s11373-005-7212-5. Epub 2005 Nov 10. J Biomed Sci. 2005. PMID: 16132110
-
Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.Biochem Biophys Res Commun. 2006 Mar 3;341(1):73-81. doi: 10.1016/j.bbrc.2005.12.164. Epub 2006 Jan 6. Biochem Biophys Res Commun. 2006. PMID: 16412380
-
Integrin-regulated FAK-Src signaling in normal and cancer cells.Curr Opin Cell Biol. 2006 Oct;18(5):516-23. doi: 10.1016/j.ceb.2006.08.011. Epub 2006 Aug 17. Curr Opin Cell Biol. 2006. PMID: 16919435 Review.
-
Signal transduction by focal adhesion kinase in cancer.Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4. Cancer Metastasis Rev. 2009. PMID: 19169797 Review.
Cited by
-
FAK is a critical regulator of neuroblastoma liver metastasis.Oncotarget. 2012 Dec;3(12):1576-87. doi: 10.18632/oncotarget.732. Oncotarget. 2012. PMID: 23211542 Free PMC article.
-
RAS Interaction with PI3K: More Than Just Another Effector Pathway.Genes Cancer. 2011 Mar;2(3):261-74. doi: 10.1177/1947601911408079. Genes Cancer. 2011. PMID: 21779497 Free PMC article.
-
Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.Am J Pathol. 2008 Nov;173(5):1540-50. doi: 10.2353/ajpath.2008.080292. Epub 2008 Oct 2. Am J Pathol. 2008. PMID: 18832579 Free PMC article.
-
Molecular Basis of LH Action on Breast Cancer Cell Migration and Invasion via Kinase and Scaffold Proteins.Front Cell Dev Biol. 2021 Feb 5;8:630147. doi: 10.3389/fcell.2020.630147. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33614634 Free PMC article.
-
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer.Genes (Basel). 2022 Sep 3;13(9):1585. doi: 10.3390/genes13091585. Genes (Basel). 2022. PMID: 36140753 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous